Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial

September 2016

Author(s): Williams JG, Alam MF, Alrubaiy L, Arnott I, Clement C, Cohen D, et al

Lancet Gastroenterol Hepatol. 2016;1(1):15-24.

NIHR Acknowledged: Yes

People
Photo Name Bio